Drugs / Polio Sabin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01262872 | Feb 2011 → Mar 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Comparator or background therapy8 trials | ||||||
| Phase 2 | NCT01098474 Background | Jul 2010 → Apr 2011 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00436007 Background | Apr 2007 → Sep 2008 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00263666 Background | Mar 2005 → Feb 2008 | Rotavirus infection | GlaxoSmithKline | Completed | Met primary |
| Phase 3 | NCT01345240 Background | Nov 2011 → Jan 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01175083 Background | Jun 2011 → Jan 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00678301 Background | Jun 2008 → Nov 2009 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00547248 Background | Oct 2007 → May 2008 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00344318 Background | Aug 2006 → Apr 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polio Sabin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01098474 ↗ |
| Modality | Vaccine | “Tritanrix HepB Hib and Polio Sabin vaccines” NCT00263666 ↗ |
| Route | Oral | “Polio Sabin™ was administered orally.” NCT00436007 ↗ |